欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/3771/001
药品名称
Lyngonia
活性成分
ARCTOSTAPHYLOS UVA-URSI (L.) SPRENG FOLIUM 425.25 mg
剂型
Film-coated tablet
上市许可持有人
Florealis ehf.
参考成员国 - 产品名称
Netherlands (NL)
Lyngonia
互认成员国 - 产品名称
Denmark (DK)
Lyngonia
Iceland (IS)
Lyngonia 425,25-519,75 mg filmuhúðuð tafla
Sweden (SE)
Norway (NO)
Lyngonia
Finland (FI)
Cyprus (CY)
ALLEVIATE
Malta (MT)
许可日期
2017/04/19
最近更新日期
2022/04/08
药物ATC编码
G04B UROLOGICALS
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Article 16a Dir 2001/83/EC
TypeLevel4:
Herbal
TypeLevel5:
Non Prescription (including OTC)
附件文件下载
Final Labelling
|
Lyngonia _ final Labelling immediate and outer packaging
Date of last change:2024/09/06
Final PL
|
Lyngonia _ final Package Leaflet
Date of last change:2024/09/06
PubAR
|
PAR_NL_H_3771_001_DC_Lyngonia_23_10_2017
Date of last change:2024/09/06
PubAR Summary
|
summaryPAR_NL_H_3771_001_DC_Lyngonia_23_10_2017_EN
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase